Canagliflozin and risk of amputation in patients with type 2 diabetes

Canagliflozin and risk of amputation in patients with type 2 diabetes

Blog Article

Sodium glucose co-transporter type 2 inhibitors (SGLT2) are a new effective group of oral hypoglygemic drugs for the treatment of diabetes type 2.At the moment there is no unanimous opinion Curling - Stabilizers on their safety.The article presents the data on clinical studies CANVAS and CANVAS-R and reports of Pourers the international database VigiBase (2015 - 2017) on the risk of amputation in patients with type 2 diabetes undergoing treatment with canagliflozin.